MKX and esophageal adenocarcinoma: In addition, a regression analysis of TCGA Esophageal Adenocarcinoma patients revealed that patients with medium MKX expression status had significantly better overall survival (HR= 0.46; 95%CI = (0.218–0.99); p = 0.047) compared to cases with low MKX expression status.